Exact Mass: 415.1995
Exact Mass Matches: 415.1995
Found 500 metabolites which its exact mass value is equals to given mass value 415.1995
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mavelertinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
I-BET151
Rupatadine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Rupatadine is a second-generation tricyclic H1-antihistamine.
4,8-Methano-8aH-bisbenzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol,7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR)-
CID 9844747
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Flesinoxan is a hypotensive agent and a potent, high affinity and selective 5-hydroxytryptamine1A (5-HT1A) receptor agonist with an EC50 value of 24 nM. Flesinoxan also has effective anxiolytic/antidepressant effects[1][2][3].
Sabeluzole
C26170 - Protective Agent > C1509 - Neuroprotective Agent
(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid
Protostemotinine
Protostemotinine is a natural product found in Stemona sessilifolia, Stemona kerrii, and Stemona japonica with data available. Protostemotinine is an alkaloid isolated from the roots and rhizomes of Stemona sessilifolia. Protostemotinine is an alkaloid isolated from the roots and rhizomes of Stemona sessilifolia.
3-benzhydryloxy-1-[2-(1,3-benzodioxol-5-yl)ethyl]piperidine
AM toxin-II|Am-II-Toxin|AM-toxin II|N-(L-2-hydroxy-3-methyl-butyryl)-5-phenyl-L-norvalyl->2,3-didehydro-alanyl->L-alanine lactone|toxin II (Alternaria mali)
(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)-3-(4-hydroxyphenyl)Propanoic acid
zamifenacin
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8319; ORIGINAL_PRECURSOR_SCAN_NO 8318 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8358; ORIGINAL_PRECURSOR_SCAN_NO 8357 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8363; ORIGINAL_PRECURSOR_SCAN_NO 8361 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8403; ORIGINAL_PRECURSOR_SCAN_NO 8402 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8404; ORIGINAL_PRECURSOR_SCAN_NO 8402 CONFIDENCE standard compound; INTERNAL_ID 734; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8409; ORIGINAL_PRECURSOR_SCAN_NO 8407 Zamifenacin (UK-76654) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome[1].
Ala Asp Asn Pro
Ala Asp Pro Asn
Ala Asn Asp Pro
Ala Asn Pro Asp
Ala Pro Asp Asn
Ala Pro Asn Asp
Ala Pro Gln Thr
Ala Pro Thr Gln
Ala Gln Pro Thr
Ala Gln Thr Pro
Ala Thr Pro Gln
Ala Thr Gln Pro
Asp Ala Asn Pro
Asp Ala Pro Asn
Asp Gly Lys Pro
Asp Gly Pro Lys
Asp Gly Pro Gln
Asp Gly Gln Pro
Asp Lys Gly Pro
Asp Lys Pro Gly
Asp Asn Ala Pro
Asp Asn Pro Ala
Asp Pro Ala Asn
Asp Pro Gly Lys
Asp Pro Gly Gln
Asp Pro Lys Gly
Asp Pro Asn Ala
Asp Pro Gln Gly
Asp Gln Gly Pro
Asp Gln Pro Gly
Glu Gly Asn Pro
Glu Gly Pro Asn
Glu Asn Gly Pro
Glu Asn Pro Gly
Glu Pro Gly Asn
Glu Pro Asn Gly
Gly Asp Lys Pro
Gly Asp Pro Lys
Gly Asp Pro Gln
Gly Asp Gln Pro
Gly Glu Asn Pro
Gly Glu Pro Asn
Gly Gly Pro Trp
Gly Gly Trp Pro
Gly Lys Asp Pro
Gly Lys Pro Asp
Gly Asn Glu Pro
Gly Asn Pro Glu
Gly Pro Asp Lys
Gly Pro Asp Gln
Gly Pro Glu Asn
Gly Pro Gly Trp
Gly Pro Lys Asp
Gly Pro Asn Glu
Gly Pro Gln Asp
Gly Pro Arg Ser
Gly Pro Ser Arg
Gly Pro Trp Gly
Gly Gln Asp Pro
Gly Gln Pro Asp
Gly Arg Pro Ser
Gly Arg Ser Pro
Gly Ser Pro Arg
Gly Ser Arg Pro
Gly Trp Gly Pro
Gly Trp Pro Gly
Lys Asp Gly Pro
Lys Asp Pro Gly
Lys Gly Asp Pro
Lys Gly Pro Asp
Lys Pro Asp Gly
Lys Pro Gly Asp
Asn Ala Asp Pro
Asn Ala Pro Asp
Asn Asp Ala Pro
Asn Asp Pro Ala
Asn Glu Gly Pro
Asn Glu Pro Gly
Asn Gly Glu Pro
Asn Gly Pro Glu
Asn Pro Ala Asp
Asn Pro Asp Ala
Asn Pro Glu Gly
Asn Pro Gly Glu
Asn Pro Ser Val
Asn Pro Val Ser
Asn Ser Pro Val
Asn Ser Val Pro
Asn Val Pro Ser
Asn Val Ser Pro
Pro Ala Asp Asn
Pro Ala Asn Asp
Pro Ala Gln Thr
Pro Ala Thr Gln
Pro Asp Ala Asn
Pro Asp Gly Lys
Pro Asp Gly Gln
Pro Asp Lys Gly
Pro Asp Asn Ala
Pro Asp Gln Gly
Pro Glu Gly Asn
Pro Glu Asn Gly
Pro Gly Asp Lys
Pro Gly Asp Gln
Pro Gly Glu Asn
Pro Gly Gly Trp
Pro Gly Lys Asp
Pro Gly Asn Glu
Pro Gly Gln Asp
Pro Gly Arg Ser
Pro Gly Ser Arg
Pro Gly Trp Gly
Pro Lys Asp Gly
Pro Lys Gly Asp
Pro Asn Ala Asp
Pro Asn Asp Ala
Pro Asn Glu Gly
Pro Asn Gly Glu
Pro Asn Ser Val
Pro Asn Val Ser
Pro Gln Ala Thr
Pro Gln Asp Gly
Pro Gln Gly Asp
Pro Gln Thr Ala
Pro Arg Gly Ser
Pro Arg Ser Gly
Pro Ser Gly Arg
Pro Ser Asn Val
Pro Ser Arg Gly
Pro Ser Val Asn
Pro Thr Ala Gln
Pro Thr Gln Ala
Pro Val Asn Ser
Pro Val Ser Asn
Pro Trp Gly Gly
Gln Ala Pro Thr
Gln Ala Thr Pro
Gln Asp Gly Pro
Gln Asp Pro Gly
Gln Gly Asp Pro
Gln Gly Pro Asp
Gln Pro Ala Thr
Gln Pro Asp Gly
Gln Pro Gly Asp
Gln Pro Thr Ala
Gln Thr Ala Pro
Gln Thr Pro Ala
Arg Gly Pro Ser
Arg Gly Ser Pro
Arg Pro Gly Ser
Arg Pro Ser Gly
Arg Ser Gly Pro
Arg Ser Pro Gly
Ser Gly Pro Arg
Ser Gly Arg Pro
Ser Asn Pro Val
Ser Asn Val Pro
Ser Pro Gly Arg
Ser Pro Asn Val
Ser Pro Arg Gly
Ser Pro Val Asn
Ser Arg Gly Pro
Ser Arg Pro Gly
Ser Val Asn Pro
Ser Val Pro Asn
Thr Ala Pro Gln
Thr Ala Gln Pro
Thr Pro Ala Gln
Thr Pro Gln Ala
Thr Gln Ala Pro
Thr Gln Pro Ala
Val Asn Pro Ser
Val Asn Ser Pro
Val Pro Asn Ser
Val Pro Ser Asn
Val Ser Asn Pro
Val Ser Pro Asn
Trp Gly Gly Pro
Trp Gly Pro Gly
Trp Pro Gly Gly
16-carboxy-17,18,19,20-tetranor-leukotriene E3
An icosanoid that is leukotriene E4 in which the non-conjugated double bond has been reduced to a single bond and four methylene groups have been lost from the resulting carboxyalkyl chain.
5,6-dimethoxy-2-methyl-3-[2-(4-phenyl-1-piperazinyl)ethyl]-1H-indole hydrochloride
Donepezil Hydrochloride
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors
Benzeneethanol, 4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]-, 4-methylbenzenesulfonate (ester)
(S)-2-TERT-BUTOXYCARBONYLAMINO-3-[4-(DIETHOXY-PHOSPHORYLMETHYL)-PHENYL]-PROPIONIC ACID
3-phenylacrylic acid (2r,3s)-3-dibenzylamino-2-hydroxybutyl ester
(S)-3-(4-ACETYLPHENYL)-4-ISOPROPYLOXAZOLIDIN-2-ONE
Celiprolol HCl
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Coelenterazine cp
(S)-2-(3-BENZOYLPHENYL)-N-(4-HYDROXYPHENETHYL)-N-ISOPROPYLPROPANAMIDE
1,11-bis(trimethoxysilyl)-4-oxa-8-azaundecan-6-ol,50 in methanol
Donetidine
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(3-pyridinylmethyl)- (9CI)
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cycloheptylpyrrolidine-1-carboxamide
methyl 2-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)ethylidene]-1,3,3-trimethylindoline-5-carboxylate
(S)-2-[2-[Bis(2-tolyl)phosphino]phenyl]-4-tert-butyl-4,5-dihydro-oxazole
3-ethynyl-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
N-([1,1-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine
ML228 (CID-46742353) is a potent the Hypoxia Inducible Factor (HIF) pathway activator with EC50 of 1 μM. ML228 potently activates HIF in vitro as well as its downstream target VEGF[1][2].
1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine Maleate
5-[[4-(2-Amino-2-oxoethoxy)-3-methoxyphenyl]methylamino]-2-(4-morpholinyl)benzoic acid
4-[3-(4-methoxyphenyl)-1H-pyrazol-5-yl]-1-[[3-(trifluoromethyl)phenyl]methyl]piperidine
1-(phenylmethyl)-N-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinecarbohydrazide
[1-acetyl-4-tert-butyl-3,6-bis(tert-butylsulfanyl)-3,6-dihydro-2H-pyridin-2-yl] acetate
(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]pyrimidin-4-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL
(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]pyrimidin-4-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL
1-{[(1E)-(3-Hydroxy-2-methyl-5-{[(trihydroxy-lambda^5^-phosphanyl)oxy]methyl}pyridin-4-YL)methylidene]amino}undecan-2-one
Rupatadine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
N-[4-(4-methylphenoxy)phenyl]-2-[2-(2-oxopyrrolidin-1-yl)anilino]acetamide
4,8-Methano-8aH-bisbenzofuro[3,2-e:2',3'-g]isoquinoline-1,8a-diol,7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR)-
17-O-deacetylvindolinium
A vinca alkaloid cation that is the conjugate acid of 17-O-deacetylvindoline.
(10S,12S)-3-acetyl-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.02,10.04,9.015,20]henicosa-4,6,8,15,17,19-hexaene-13,21-dione
(2S)-2-[[(2S)-2-Amino-3-(1H-imidazol-5-yl)propanoyl]-(2-benzamidoethyl)amino]-4-methylpentanoic acid
Ala-Asn-Asp-Pro
A tetrapeptide composed of L-alanyl, L-asparagyl, L-aspartyl, and L-proline residues joined in sequence.
3,6-Bis(dimethylamino)-9-(2-(ethoxycarbonyl)-phenyl)xanthylium
6-phenyl-N-[(3-phenylphenyl)methyl]-3-(2-pyridinyl)-1,2,4-triazin-5-amine
2-[(chloroacetyl)(4-methoxyphenyl)amino]-N-cyclohexyl-2-pyridin-3-ylacetamide
1-[3-[(7-Cyano-[1,3]dioxolo[4,5-g]quinolin-6-yl)amino]propyl]-3-(3-ethoxypropyl)thiourea
(3S,3aR,8aS,8bS)-5-ethyl-2-(phenylmethyl)spiro[1H-indole-3,4-3a,6,7,8,8a,8b-hexahydropyrrolo[3,4-a]pyrrolizine]-1,2,3-trione
1-acetyl-N-[3-(N-ethyl-3-methylanilino)propyl]-2,3-dihydroindole-5-sulfonamide
1-(4-tert-butylphenyl)sulfonyl-N-(2-pyridinylmethyl)-2-piperidinecarboxamide
5-(Pentoxymethyl)-3-[(2E)-2-[(4-phenyl-1,3-thiazol-2-yl)hydrazinylidene]propyl]oxolan-2-one
(12R,15S,16R,8R)-15-methoxy-7,8,10-trimethyl-6,9-dioxo-13,14,15,16-tetrahydro-12H-4-oxa-7,10-diaza-1(2,6)-pyrana-5(1,2)-benzenacycloundecaphane-56-carbonitrile
[2-(2,5-dimethylanilino)-2-oxoethyl] (E)-3-(2-methoxyphenyl)-2-phenylprop-2-enoate
1-(5,6-Dihydrobenzo[b][1]benzazepin-11-yl)-2-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]ethanone
(1S,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
4-[(3aR,4R,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aS,4R,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aR,4S,9bR)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
2-[(2R,5R,6S)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-[(2S,5S,6S)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
(1S,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13R,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13R,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13R,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,12S,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12R,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
[(1R,2aR,8bR)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
[(1S,2aR,8bR)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
1-[(2R,3R)-6-[(2,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
4-[4-[(2S,3R)-1-acetyl-6-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-3-yl]phenyl]benzonitrile
4-[4-[(2R,3R)-1-acetyl-6-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-3-yl]phenyl]benzonitrile
2-[(2R,5S,6R)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-[(2S,5R,6S)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-[(2S,5S,6R)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-[(2R,5R,6R)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-[(2R,5S,6S)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-[(2S,5R,6R)-5-[[(2-fluoroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-(phenylmethyl)acetamide
2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
2-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[1-oxo-2-(2-pyridinyl)ethyl]amino]ethyl]-3-oxanyl]benzamide
(1S,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13S,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1S,13S,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13S,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5,7,9-triene-6-carbonitrile
(1R,13R,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17S,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,13R,17S,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1S,13S,17R,18S)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,17R,18R)-18-methoxy-12,13,15-trimethyl-11,14-dioxo-4,21-dioxa-12,15-diazatricyclo[15.3.1.05,10]henicosa-5(10),6,8-triene-8-carbonitrile
(1R,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1S,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4(9),5,7-triene-7-carbonitrile
(1R,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12R,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17S,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17S,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1R,12S,17R,20S)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
(1S,12R,17R,20R)-20-methoxy-11,12,14-trimethyl-10,13-dioxo-3,21-dioxa-11,14-diazatricyclo[15.3.1.04,9]henicosa-4,6,8-triene-5-carbonitrile
[(1R,2aS,8bS)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-2-[(3-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-pyridin-4-ylmethanone
4-[(3aS,4S,9bS)-1-[cyclohexyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
1-[(2S,3R)-6-[(2,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-1-yl]-2-(dimethylamino)ethanone
4-[4-[(2S,3S)-1-acetyl-6-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-1,6-diazaspiro[3.3]heptan-3-yl]phenyl]benzonitrile
(2R,3R)-6-[(3,5-difluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-1-carboxamide
(1S,17S,19S)-16,16-dimethyl-14-oxido-7,10,23,25-tetraza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.06,11.019,23]hexacosa-2,4,6,8,10,12,14-heptaene-24,26-dione
ALM301
ALM301 is an orally active highly specific AKT inhibitor with IC50 values of 0.13 μM, 0.09 μM and 2.75 μM for AKT1, AKT2 and AKT3, respectively. ALM301 inhibits AKT phosphorylation and modulates downstream signalling in vitro. ALM301 can inhibit cancer cell proliferation and tumor growth[1].
BC1618
BC1618, an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling (via preventing activated pAmpkα from Fbxo48-mediated degradation). BC1618 promotes mitochondrial fission, facilitates autophagy and improves hepatic insulin sensitivity[1].
Ninerafaxstat
Ninerafaxstat (IMB-1018972) is a novel mitotropic agent. Ninerafaxstat increases myocardial metabolic efficiency by shifting substrate utilization towards glucose through reducing fatty acid oxidation (inhibiting 3-ketoacyl CoA thiolase). Ninerafaxstat can be used for the research of cardiovascular diseases[1].